176750 — Duchembio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Duchembio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20,282	10,985	32,422	34,695	35,601
Cost of Revenue
Gross Profit	4,761	3,201	8,699	11,797	12,234
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	26,226	10,533	32,057	29,470	30,525
Operating Profit	-5,944	452	366	5,225	5,076
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-7,917	1,447	-2,697	4,052	5,564
Provision for Income Taxes
Net Income After Taxes	-7,876	1,447	-2,832	4,001	7,994
Minority Interest
Net Income Before Extraordinary Items
Net Income	-7,339	1,520	-2,601	4,001	7,994
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-7,339	1,520	-2,601	4,001	7,994
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-636	56.9	-23.8	150	298
Dividends per Share